vs
Assertio Holdings, Inc.（ASRT）与BGSF, INC.（BGSF）财务数据对比。点击上方公司名可切换其他公司
BGSF, INC.的季度营收约是Assertio Holdings, Inc.的1.6倍（$22.0M vs $13.5M），BGSF, INC.同比增速更快（-9.4% vs -57.9%），过去两年BGSF, INC.的营收复合增速更高（-5.3% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
BGSF Inc.是一家总部位于美国的领先人力资源解决方案提供商，提供定制化人员派遣、人才招聘和全流程劳动力管理服务，覆盖信息技术、医疗健康、专业行政、轻工业、创意产业等核心领域，服务北美各规模的企业客户。
ASRT vs BGSF — 直观对比
营收规模更大
BGSF
是对方的1.6倍
$13.5M
营收增速更快
BGSF
高出48.5%
-57.9%
两年增速更快
BGSF
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $22.0M |
| 净利润 | — | $-1.2M |
| 毛利率 | — | 35.0% |
| 营业利润率 | -86.7% | -17.6% |
| 净利率 | — | -5.3% |
| 营收同比 | -57.9% | -9.4% |
| 净利润同比 | — | -18.2% |
| 每股收益（稀释后） | $-4.54 | $-0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTBGSF
| Q4 25 | $13.5M | $22.0M | ||
| Q3 25 | $49.5M | $26.9M | ||
| Q2 25 | $29.2M | $23.5M | ||
| Q1 25 | $26.5M | $20.9M | ||
| Q4 24 | $32.2M | $24.3M | ||
| Q3 24 | $29.2M | $29.8M | ||
| Q2 24 | $31.1M | $25.7M | ||
| Q1 24 | $32.4M | $24.5M |
净利润ASRTBGSF
| Q4 25 | — | $-1.2M | ||
| Q3 25 | $11.4M | $-5.8M | ||
| Q2 25 | $-16.4M | $-3.7M | ||
| Q1 25 | $-13.5M | $-722.0K | ||
| Q4 24 | — | $-981.0K | ||
| Q3 24 | $-2.9M | $-804.0K | ||
| Q2 24 | $-3.7M | $-761.0K | ||
| Q1 24 | $-4.5M | $-792.0K |
毛利率ASRTBGSF
| Q4 25 | — | 35.0% | ||
| Q3 25 | — | 35.9% | ||
| Q2 25 | — | 35.8% | ||
| Q1 25 | — | 36.2% | ||
| Q4 24 | — | 35.9% | ||
| Q3 24 | — | 35.9% | ||
| Q2 24 | — | 37.3% | ||
| Q1 24 | — | 38.1% |
营业利润率ASRTBGSF
| Q4 25 | -86.7% | -17.6% | ||
| Q3 25 | 23.2% | -3.5% | ||
| Q2 25 | -27.5% | -18.8% | ||
| Q1 25 | -50.0% | 1.6% | ||
| Q4 24 | -41.9% | -15.7% | ||
| Q3 24 | -10.4% | -3.4% | ||
| Q2 24 | -11.6% | -5.7% | ||
| Q1 24 | -13.4% | 1.7% |
净利率ASRTBGSF
| Q4 25 | — | -5.3% | ||
| Q3 25 | 23.1% | -21.6% | ||
| Q2 25 | -56.0% | -15.9% | ||
| Q1 25 | -51.1% | -3.5% | ||
| Q4 24 | — | -4.0% | ||
| Q3 24 | -10.0% | -2.7% | ||
| Q2 24 | -11.8% | -3.0% | ||
| Q1 24 | -13.9% | -3.2% |
每股收益（稀释后）ASRTBGSF
| Q4 25 | $-4.54 | $-0.12 | ||
| Q3 25 | $0.11 | $-0.52 | ||
| Q2 25 | $-0.17 | $-0.34 | ||
| Q1 25 | $-0.14 | $-0.06 | ||
| Q4 24 | $-3.28 | — | ||
| Q3 24 | $-0.03 | $-0.07 | ||
| Q2 24 | $-0.04 | $-0.07 | ||
| Q1 24 | $-0.05 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $48.1M |
| 总资产 | $267.0M | $57.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTBGSF
| Q4 25 | $63.4M | — | ||
| Q3 25 | $93.4M | $41.2M | ||
| Q2 25 | $98.2M | $2.8M | ||
| Q1 25 | $87.3M | $2.0M | ||
| Q4 24 | $100.1M | $32.0K | ||
| Q3 24 | $88.6M | $262 | ||
| Q2 24 | $88.4M | $226 | ||
| Q1 24 | $80.7M | $50 |
总债务ASRTBGSF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTBGSF
| Q4 25 | $94.0M | $48.1M | ||
| Q3 25 | $105.8M | $50.7M | ||
| Q2 25 | $93.3M | $78.3M | ||
| Q1 25 | $108.5M | $81.8M | ||
| Q4 24 | $121.1M | $82.3M | ||
| Q3 24 | $130.5M | $82.9M | ||
| Q2 24 | $132.2M | $83.2M | ||
| Q1 24 | $134.5M | $83.6M |
总资产ASRTBGSF
| Q4 25 | $267.0M | $57.8M | ||
| Q3 25 | $319.8M | $83.6M | ||
| Q2 25 | $273.8M | $149.7M | ||
| Q1 25 | $286.4M | $152.3M | ||
| Q4 24 | $284.7M | $150.1M | ||
| Q3 24 | $276.0M | $157.3K | ||
| Q2 24 | $279.4M | $159.8K | ||
| Q1 24 | $282.0M | $170.6K |
负债/权益比ASRTBGSF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | — | $1.7M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-16.0K |
8季度趋势，按日历期对齐
经营现金流ASRTBGSF
| Q4 25 | $-30.0M | $1.7M | ||
| Q3 25 | $-4.8M | $-4.8M | ||
| Q2 25 | $19.1M | $2.2M | ||
| Q1 25 | $-12.5M | $1.1M | ||
| Q4 24 | $11.5M | $3.2M | ||
| Q3 24 | $-35.0K | $6.5M | ||
| Q2 24 | $7.4M | $7.3M | ||
| Q1 24 | $7.5M | $7.4M |
自由现金流ASRTBGSF
| Q4 25 | — | $1.7M | ||
| Q3 25 | — | $-4.9M | ||
| Q2 25 | — | $2.1M | ||
| Q1 25 | — | $1.0M | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | — | $6.5M | ||
| Q2 24 | — | $7.3M | ||
| Q1 24 | — | $6.9M |
自由现金流率ASRTBGSF
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | -18.1% | ||
| Q2 25 | — | 9.1% | ||
| Q1 25 | — | 5.0% | ||
| Q4 24 | — | 10.2% | ||
| Q3 24 | — | 21.7% | ||
| Q2 24 | — | 28.5% | ||
| Q1 24 | — | 28.1% |
资本支出强度ASRTBGSF
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 2.0% |
现金转化率ASRTBGSF
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
BGSF
| Contract Field Talent | $21.4M | 97% |
| Other | $595.0K | 3% |
